South Korea · Delayed Price · Currency is KRW GeneOne Life Science Statistics
Total Valuation
KRX:011000 has a market cap or net worth of KRW 65.28 billion. The enterprise value is 96.51 billion.
| Market Cap | 65.28B |
| Enterprise Value | 96.51B |
Important Dates
The next estimated earnings date is Thursday, May 14, 2026.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
KRX:011000 has 90.67 million shares outstanding. The number of shares has increased by 3.77% in one year.
| Current Share Class | 90.67M |
| Shares Outstanding | 90.67M |
| Shares Change (YoY) | +3.77% |
| Shares Change (QoQ) | -2.97% |
| Owned by Insiders (%) | 6.78% |
| Owned by Institutions (%) | 3.68% |
| Float | 74.17M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.83 |
| PB Ratio | 1.60 |
| P/TBV Ratio | 1.60 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.86 |
| EV / Sales | 4.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -5.83 |
Financial Position
The company has a current ratio of 0.36, with a Debt / Equity ratio of 0.81.
| Current Ratio | 0.36 |
| Quick Ratio | 0.07 |
| Debt / Equity | 0.81 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.99 |
| Interest Coverage | -8.57 |
Financial Efficiency
Return on equity (ROE) is -81.98% and return on invested capital (ROIC) is -29.50%.
| Return on Equity (ROE) | -81.98% |
| Return on Assets (ROA) | -20.35% |
| Return on Invested Capital (ROIC) | -29.50% |
| Return on Capital Employed (ROCE) | -67.33% |
| Weighted Average Cost of Capital (WACC) | 9.48% |
| Revenue Per Employee | 562.07M |
| Profits Per Employee | -1.26B |
| Employee Count | 41 |
| Asset Turnover | 0.17 |
| Inventory Turnover | 2.56 |
Taxes
| Income Tax | -86.36M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -62.10% in the last 52 weeks. The beta is 0.69, so KRX:011000's price volatility has been lower than the market average.
| Beta (5Y) | 0.69 |
| 52-Week Price Change | -62.10% |
| 50-Day Moving Average | 1,209.44 |
| 200-Day Moving Average | 1,944.82 |
| Relative Strength Index (RSI) | 37.20 |
| Average Volume (20 Days) | 2,205,858 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:011000 had revenue of KRW 23.04 billion and -51.85 billion in losses. Loss per share was -629.00.
| Revenue | 23.04B |
| Gross Profit | -15.22B |
| Operating Income | -44.04B |
| Pretax Income | -51.94B |
| Net Income | -51.85B |
| EBITDA | -25.84B |
| EBIT | -44.04B |
| Loss Per Share | -629.00 |
Balance Sheet
The company has 1.73 billion in cash and 32.96 billion in debt, with a net cash position of -31.22 billion or -344.35 per share.
| Cash & Cash Equivalents | 1.73B |
| Total Debt | 32.96B |
| Net Cash | -31.22B |
| Net Cash Per Share | -344.35 |
| Equity (Book Value) | 40.90B |
| Book Value Per Share | 496.77 |
| Working Capital | -34.37B |
Cash Flow
In the last 12 months, operating cash flow was -16.54 billion and capital expenditures -23.82 million, giving a free cash flow of -16.56 billion.
| Operating Cash Flow | -16.54B |
| Capital Expenditures | -23.82M |
| Depreciation & Amortization | 18.20B |
| Net Borrowing | 16.40B |
| Free Cash Flow | -16.56B |
| FCF Per Share | -182.69 |
Margins
Gross margin is -66.03%, with operating and profit margins of -191.09% and -225.00%.
| Gross Margin | -66.03% |
| Operating Margin | -191.09% |
| Pretax Margin | -225.38% |
| Profit Margin | -225.00% |
| EBITDA Margin | -112.13% |
| EBIT Margin | -191.09% |
| FCF Margin | n/a |
Dividends & Yields
KRX:011000 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3.77% |
| Shareholder Yield | -3.77% |
| Earnings Yield | -79.42% |
| FCF Yield | -25.37% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 3, 2021. It was a forward split with a ratio of 1.5.
| Last Split Date | Dec 3, 2021 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
KRX:011000 has an Altman Z-Score of -3.63 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.63 |
| Piotroski F-Score | 1 |